Citation Impact
Citing Papers
Presence of Candida cell wall derived polysaccharides in the sera of intensive care unit patients: relation with candidaemia and Candida colonisation
2014
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
In Vitro Activities of Posaconazole, Fluconazole, Itraconazole, Voriconazole, and Amphotericin B against a Large Collection of Clinically Important Molds and Yeasts
2006
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Epidemiology of Invasive Mycoses in North America
2010
Invasive Aspergillosis in Hematological Patients
2016
Optimization of the Cutoff Value for the Aspergillus Double-Sandwich Enzyme Immunoassay
2007
British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE
2013 Standout
Review on plant antimicrobials: a mechanistic viewpoint
2019 Standout
Aspergillosis: Spectrum of Disease, Diagnosis, and Treatment
2006
Detection of Galactomannan Antigenemia by Enzyme Immunoassay for the Diagnosis of Invasive Aspergillosis: Variables That Affect Performance
2004
Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials
2012 Standout
1,3- -D-Glucan Antigenemia for Early Diagnosis of Invasive Fungal Infections in Neutropenic Patients with Acute Leukemia
2008
Diagnosis of Invasive Aspergillosis Using a Galactomannan Assay: A Meta-Analysis
2006
Galactomannan Antigenemia in Pediatric Oncology Patients With Invasive Aspergillosis
2008
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
New antifungal drugs and new clinical trials
2003
Antifungal Therapy Decreases Sensitivity of theAspergillus Galactomannan Enzyme Immunoassay
2005
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
2007 Standout
Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients
2008
Clinical utility and prognostic value of bronchoalveolar lavage galactomannan in patients with hematologic malignancies
2010
Galactomannan detection for invasive aspergillosis in immunocompromized patients
2008
Imaging Findings in Acute Invasive Pulmonary Aspergillosis: Clinical Significance of the Halo Sign
2007
Interleukin-10 promoter polymorphism as risk factor to develop invasive pulmonary aspergillosis
2007
Clinical Issues Regarding Relapsing Aspergillosis and the Efficacy of Secondary Antifungal Prophylaxis in Patients with Hematological Malignancies
2006
AspergillusPolymerase Chain Reaction: Systematic Review of Evidence for Clinical Use in Comparison With Antigen Testing
2015
Prospective Aspergillus Galactomannan Antigen Testing in Pediatric Hematopoietic Stem Cell Transplant Recipients
2007
Fungal infections in solid organ transplantation
2007
Management of infections related to totally implantable venous-access ports: challenges and perspectives
2013
Immediate versus deferred empirical antifungal (IDEA) therapy in high-risk patients with febrile neutropenia: a randomized, double-blind, placebo-controlled, multicenter study
2012
False‐Positive Galactomannan PlateliaAspergillusTest Results for Patients Receiving Piperacillin‐Tazobactam
2004
Candida albicanspathogenicity mechanisms
2013 Standout
Prospective clinical evaluation of a LightCyclerTM‐mediated polymerase chain reaction assay, a nested‐PCR assay and a galactomannan enzyme‐linked immunosorbent assay for detection of invasive aspergillosis in neutropenic cancer patients and haematological stem cell transplant recipients
2004
Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study
2010
Galactomannan detection in computerized tomography‐based broncho‐alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis
2003
Bad Bugs Need Drugs: An Update on the Development Pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America
2006 Standout
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Infections in patients with cancer undergoing chemotherapy: aetiology, prevention, and treatment
2003
Performance of the galactomannan antigen detection test in the diagnosis of invasive aspergillosis in children with cancer or undergoing haemopoietic stem cell transplantation
2010
Newer Systemic Antifungal Agents
2004
Nocardiosis at the Turn of the Century
2009 Standout
Rapid diagnosis of invasive aspergillosis by antigen detection
2003
Infections due to emerging and uncommon medically important fungal pathogens
2004
Posaconazole: a broad-spectrum triazole antifungal
2005
Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease
2007
Hospital construction-associated outbreak of ocular aspergillosis after cataract surgery11The authors have no proprietary interest in any of the materials used in this study.
1998
Fusobacterium nucleatum: a commensal-turned pathogen
2015 Standout
Threshold of galactomannan antigenemia positivity for early diagnosis of invasive aspergillosis in neutropenic children
2014
Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies
2007
ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients
2011
Posaconazole: A Broad-Spectrum Triazole Antifungal Agent
2007
Mechanisms of drug combinations: interaction and network perspectives
2009 Standout
Galactomannan Does Not Precede Major Signs on a Pulmonary Computerized Tomographic Scan Suggestive of Invasive Aspergillosis in Patients with Hematological Malignancies
2005
The challenge of emerging and re-emerging infectious diseases
2004 StandoutNature
IL1 Gene Cluster Polymorphisms and Its Haplotypes may Predict the Risk to Develop Invasive Pulmonary Aspergillosis and Modulate C-reactive Protein Level
2008
Changing epidemiology of systemic fungal infections
2008
Prospective Assessment of Platelia™Aspergillus Galactomannan Antigen for the Diagnosis of Invasive Aspergillosis in Lung Transplant Recipients
2004
Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses
2016 Standout
Treatment with Piperacillin‐Tazobactam and False‐PositiveAspergillusGalactomannan Antigen Test Results for Patients with Hematological Malignancies
2004
The Top 10 fungal pathogens in molecular plant pathology
2012 Standout
Correlation between high-resolution computed tomography and galactomannan antigenemia in adult hematologic patients at risk for invasive aspergillosis
2008
New strategies of antifungal therapy in hematopoietic stem cell transplant recipients and patients with hematological malignancies
2006
Advances in the serological diagnosis of invasive Aspergillus infections in patients with haematological disorders
2007
Prevention and Early Treatment of Invasive Fungal Infection in Patients with Cancer and Neutropenia and in Stem Cell Transplant Recipients in the Era of Newer Broad-Spectrum Antifungal Agents and Diagnostic Adjuncts
2007
Mycoses in Pediatric Patients
2006
Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study
2011
Advances and challenges in management of invasive mycoses
2005
Co-infections in people with COVID-19: a systematic review and meta-analysis
2020 Standout
Mold Infections of the Central Nervous System
2014
Immunity to fungal infections
2011 Standout
Clinical evaluation of Aspergillus‐PCR for detection of invasive aspergillosis in immunosuppressed patients
2005
Galactomannan Antigen Testing for Diagnosis of Invasive Aspergillosis in Pediatric Hematology Patients
2012
Galactomannan and Computed Tomography-Based Preemptive Antifungal Therapy in Neutropenic Patients at High Risk for Invasive Fungal Infection: A Prospective Feasibility Study
2005
Candida albicans Infection Affords Protection against Reinfection via Functional Reprogramming of Monocytes
2012 Standout
Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis
2004
Correlation between galactomannan antigen levels in serum and neutrophil counts in haematological patients with invasive aspergillosis
2008
Diagnostic potential of nested PCR, galactomannan EIA, and Beta-D-glucan for invasive aspergillosis in pediatric patients
2012
Epidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant Recipients
2002 Standout
The invasive and saprophytic syndromes due toAspergillusspp.
2005
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
2007 Standout
Tie2-dependent VHL knockdown promotes airway microvascular regeneration and attenuates invasive growth of Aspergillus fumigatus
2013 StandoutNobel
Fusobacterium nucleatum — symbiont, opportunist and oncobacterium
2018 Standout
Antibody testing in aspergillosis—quo vadis?
2015
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Candidemia in Norway (1991 to 2003): Results from a Nationwide Study
2006
Pulmonary rehabilitation for chronic obstructive pulmonary disease
2015 Standout
Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.
2009
Fusarium, a Significant Emerging Pathogen in Patients With Hematologic Malignancy: Ten Years' Experience at a Cancer Center and Implications for Management
1997
Evolution of Invasion in a Diverse Set of Fusobacterium Species
2014
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
2016 Standout
Diagnosing Invasive Aspergillosis during Antifungal Therapy by PCR Analysis of Blood Samples
2004
Prevention and Treatment of Cancer-Related Infections
2012
Fusarium Infections in Immunocompromised Patients
2007
Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision
2017 Standout
Laboratory diagnosis of invasive aspergillosis
2005
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Serum galactomannan assay for the diagnosis of invasive aspergillosis in children with haematological malignancies
2013
Combination Antifungal Therapy
2004
Klebsiella pneumoniae: Going on the Offense with a Strong Defense
2016 Standout
AspergillusGalactomannan Enzyme Immunoassay and Quantitative PCR for Diagnosis of Invasive Aspergillosis with Bronchoalveolar Lavage Fluid
2004
Invasive Candidiasis
2015 Standout
2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adultsa
2015 Standout
Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
2003 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Use and Limits of (1-3)-β- d -Glucan Assay (Fungitell), Compared to Galactomannan Determination (Platelia Aspergillus), for Diagnosis of Invasive Aspergillosis
2014
Consenso Manejo racional del paciente con cáncer, neutropenia y fiebre: Rational approach towards the patient with cancer, fever and neutropenia
2005
Fluorine in medicinal chemistry: Recent therapeutic applications of fluorinated small molecules
2006 Standout
Rare and Emerging Opportunistic Fungal Pathogens: Concern for Resistance beyondCandida albicansandAspergillus fumigatus
2004
Utility of Galactomannan Enzyme Immunoassay and (1,3) β- d -Glucan in Diagnosis of Invasive Fungal Infections: Low Sensitivity for Aspergillus fumigatus Infection in Hematologic Malignancy Patients
2008
Laboratory Diagnosis of Invasive Aspergillosis: From Diagnosis to Prediction of Outcome
2013
Biofilm-Related Infections: Bridging the Gap between Clinical Management and Fundamental Aspects of Recalcitrance toward Antibiotics
2014 Standout
Detection of Circulating Aspergillus fumigatus Galactomannan: Value and Limits of the Platelia Test for Diagnosing Invasive Aspergillosis
2003
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Occurrence and Kinetics of False-PositiveAspergillusGalactomannan Test Results following Treatment with β-Lactam Antibiotics in Patients with Hematological Disorders
2006
HOW NEUTROPHILS KILL MICROBES
2005 Standout
Hidden Killers: Human Fungal Infections
2012 Standout
The roles of CDR1, CDR2, and MDR1 in kaempferol-induced suppression with fluconazole-resistant Candida albicans
2015
Prospective Comparison of the Diagnostic Potential of Real-Time PCR, Double-Sandwich Enzyme-Linked Immunosorbent Assay for Galactomannan, and a (1→3)-β- d -Glucan Test in Weekly Screening for Invasive Aspergillosis in Patients with Hematological Disorders
2004
Works of J. Waller being referenced
Successful treatment of Fusarium proliferatum pneumonia with posaconazole in a lung transplant recipient
2004
Combination of caspofungin and an azole or an amphotericin B formulation in invasive fungal infections
2005
Epidemiological study of invasive pulmonary aspergillosis in a haematology unit by molecular typing of environmental and patient isolates of Aspergillus fumigatus
2005
Chronic DisseminatedTrichosporon asahiiInfection in a Leukemic Child
2002
Isolated Renal Aspergillus Abscess in an AIDS Patient with a Normal CD4+ Cell Count on Highly Active Antiretroviral Therapy
1999
Acremonium strictum Pulmonary Infection in a Leukemic Patient Successfully Treated with Posaconazole After Failure of Amphotericin B
2002
Antifungal Activity of Sodium Bicarbonate Against Fungal Agents Causing Superficial Infections
2012
[Rare opportunistic fungal diseases in patients with organ or bone marrow transplantation].
1992
AspergillusGalactomannan Detection in the Diagnosis of Invasive Aspergillosis in Cancer Patients
2002
[Invasive aspergillosis in immunocompromised patients. An analysis of 57 patients].
1992
Comparison of Mycosis IC/F and Plus Aerobic/F Media for Diagnosis of Fungemia by the Bactec 9240 System
2004
Successful Outcome of Treatment of a Disseminated Infection Due toFusarium dimerumin a Leukemia Patient
2002
Post-traumatic intracranial epiduralAspergillus fumigatusabscess
1997